ND
Nilima Dayanand Rao
About Nilima Dayanand Rao
Nilima Dayanand Rao has 30 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Remidex Pharma Private Limited and Sanil Pharmaceuticals Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Remidex Pharma Private Limited
U24231KA1981PTC004260
|
Managing Director | 24 Jan 2017 | 1981 | Active |
Sanil Pharmaceuticals Private Limited
U24239KA1989PTC010426
|
Director | 30 Sep 1995 | 1989 | Active |
Ishaan Labs Private Limited
U24233KA1995PTC018262
|
Director | 24 Jan 2017 | 1995 | Active |
Surima Ventures Llp
ACL-6273
|
Designated Partner | 27 Jan 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Sachidanand Cassettes Private Limited
U85110KA1995PTC019049
|
Director | 25 Oct 1995 | 1995 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilima Dayanand Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilima Dayanand Rao
Nilima Dayanand Rao has 30 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Remidex Pharma Private Limited and Sanil Pharmaceuticals Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Nilima Dayanand Rao is associated with 4 companies as Managing Director and Director.
Nilima Dayanand Rao has expertise in General Business.
Nilima Dayanand Rao has 30 years in corporate governance.